Healthcare AI

Twitter

Facebook

Copy Link

Key Facts

Key PlayersTempus, Viz.ai, Nuance

AI AdoptionGrowing

Use CasesMedical Imaging, Clinical Decision Support, Patient Triage

Top News

Penn Medicine's AI Model Detects Hidden Diseases in 400,000 CT Scans

Penn Medicine researchers developed Percival, an AI model trained on 400,000 CT scans from 50,000 patients that detects hidden diseases beyond the original scan purpose. The model identifies conditions like atrial fibrillation, chronic kidney disease, and pancreatic cancer more reliably than existing AI tools, enabling opportunistic screening for early detection of diseases.

Health2 sources

Penn Medicine's AI Model Detects Hidden Diseases in 400,000 CT Scans

Health2 sources

AstraZeneca and Oracle Partner to Accelerate Patient Recruitment Using AI in Clinical Trials

AstraZeneca has partnered with Oracle to deploy AI and real patient health data in clinical trials, aiming to speed up patient recruitment and improve drug safety monitoring. The first project launches in Abu Dhabi with M42, targeting uncontrolled hypertension, with plans to expand across cancer, heart disease, and rare diseases in the US, Middle East, and Europe.

Technology3 sources

AstraZeneca and Oracle Partner to Accelerate Patient Recruitment Using AI in Clinical Trials

Technology3 sources

Samsung Solve for Tomorrow Awards ₹2 Crore in Incubation Grants to Four AI-Driven Solutions

Samsung India announced four winning teams at Samsung Solve for Tomorrow 2026, awarding ₹2 crore in incubation grants for AI-driven solutions tackling cybersecurity, autism care, wildlife detection, and sports injury prevention. The nationwide innovation challenge saw participation from 648 cities across 28 states and seven union territories.

Technology2 sources

Samsung Solve for Tomorrow Awards ₹2 Crore in Incubation Grants to Four AI-Driven Solutions

Technology2 sources

AI Detects Stress by Analyzing Routine Smartphone Behaviors, KAIST Researchers Achieve 75.9% Accuracy

KAIST researchers unveiled SHIRBT-MMF, an AI system that detects daily stress by analyzing routine smartphone behaviors like messenger chatting and financial payments. The technology achieved 75.9% accuracy in identifying stress levels while maintaining privacy through data hashing, outperforming conventional app-usage tracking methods.

Health2 sources

AI Detects Stress by Analyzing Routine Smartphone Behaviors, KAIST Researchers Achieve 75.9% Accuracy

Health2 sources

Confido Health Secures $12.5M to Scale AI Agents for Healthcare Administration Automation

US-based healthtech startup Confido Health raised $12.5 million in a Series A extension led by Z47, bringing total funding to $22.5 million. The company's AI agents automate administrative tasks for healthcare providers across 1,500 sites in 27 states, achieving 95% handling rates and adding capacity equivalent to three to five full-time employees within three months.

Startups2 sources

Confido Health Secures $12.5M to Scale AI Agents for Healthcare Administration Automation

Startups2 sources

AstraZeneca strikes $1.5 billion AI drug discovery deal with insitro for liver and heart diseases

AstraZeneca has partnered with AI biotech company insitro in a deal worth up to $1.5 billion to identify treatments for MASH and cardiomyopathies. Insitro will receive $40 million upfront and could earn up to $1.46 billion in milestone payments. The collaboration uses insitro's Virtual Human AI platform to pinpoint disease drivers and accelerate drug targets identification.

Health7 sources

AstraZeneca strikes $1.5 billion AI drug discovery deal with insitro for liver and heart diseases

Health7 sources

DataMEDS AI Secures Exclusive U.S. Rights to REBOOT Health AI's GLP-1 Weight Management Platform

DataMEDS AI has entered an exclusive license and revenue sharing agreement with REBOOT Health AI for Direct-To-Consumer GLP-1 weight management platform rights in the United States. The platform will be integrated into the Health Lives Here mobile app as subscription-based services, combining AI-enhanced chronic disease management with data-driven healthcare solutions.

Business2 sources

DataMEDS AI Secures Exclusive U.S. Rights to REBOOT Health AI's GLP-1 Weight Management Platform

Business2 sources

Zealand Pharma and Generate Biomedicines forge $1.2 billion AI drug partnership for obesity treatments

Zealand Pharma and Generate Biomedicines announced a strategic collaboration worth up to $1.2 billion to develop AI-engineered protein therapies for obesity and metabolic diseases. Generate will receive $30 million upfront and leverage its generative AI platform for drug discovery, while Zealand Pharma will handle clinical development and commercialization of the protein therapeutics.

Business5 sources

Zealand Pharma and Generate Biomedicines forge $1.2 billion AI drug partnership for obesity treatments

Business5 sources

AI Tool Detects Early Psychosis Risk in Youth with 93% Accuracy from Short Speech Samples

Researchers at Nanyang Technological University and the Institute of Mental Health developed LEMon-AID, an emotion-focused AI that identifies early signs of psychosis in youths from 45-second speech samples. The AI tool achieves 93% detection sensitivity by analyzing emotional cues in speech, addressing a critical gap in early intervention for mental health.

Health2 sources

AI Tool Detects Early Psychosis Risk in Youth with 93% Accuracy from Short Speech Samples

Health2 sources

Nvidia Expands European AI Footprint With Minority Investment in Doctolib and Three Other French Startups

AI chip giant Nvidia is acquiring minority stakes in four French tech startups—Doctolib, Genesis AI, Pigment, and Entalpic—as CEO Jensen Huang announced in Paris. The move strengthens Nvidia's presence in Europe's AI ecosystem, supporting healthcare AI platform development, robotics, enterprise planning software, and scientific research applications.

Startups4 sources

Nvidia Expands European AI Footprint With Minority Investment in Doctolib and Three Other French Startups

Startups4 sources

AI Platform Enables Real-Time Conversation Between Epilepsy Patients and Their Medical Devices

University of Pennsylvania researchers have developed an AI platform that allows epilepsy patients to interact with their brain monitoring devices through a smartphone app. The proof-of-concept study with 13 patients demonstrates how conversational AI agents can enable real-time patient-device interaction for adaptive healthcare.

Health5 sources

AI Platform Enables Real-Time Conversation Between Epilepsy Patients and Their Medical Devices

Health5 sources

AI System Achieves 99.6% Accuracy in Rabies Virus Detection, Transforming Global Testing

University of Surrey researchers developed the first AI system for rabies virus detection in cell cultures, achieving 99.6% accuracy. The AI-based workflow analyzes fluorescence images to identify infections and measure vaccine-induced antibody levels, replacing manual microscopy. The breakthrough could accelerate rabies virus detection in endemic countries where the disease kills 59,000 people annually.

Health2 sources

AI System Achieves 99.6% Accuracy in Rabies Virus Detection, Transforming Global Testing

Health2 sources

Trump Officials Grant Tech Giants Direct Access to Shape AI in Healthcare Through Private Slack Channel

The Trump administration has been running a private Slack chat room where tech giants including Microsoft, OpenAI, Google, and Apple directly influence federal policy on AI in healthcare. At least 35 industry organizations attended closed-door FDA meetings on conversational AI products for patients, bypassing public oversight while shaping regulations for AI-powered healthcare apps that could soon bill Medicare.

Policy2 sources

Trump Officials Grant Tech Giants Direct Access to Shape AI in Healthcare Through Private Slack Channel

Policy2 sources

India Bans AI-Generated Medical Ads and Fake Patient Testimonials Under New NMC Guidelines

The National Medical Commission has banned doctors and hospitals from using AI-generated patient testimonials, fabricated clinical outcomes, and misleading promotional content. The new ethical advertising guidelines prohibit paid patient solicitation, manipulated search engine rankings, and unverified cure claims, with penalties ranging from warnings to license suspension for violations.

Policy2 sources

India Bans AI-Generated Medical Ads and Fake Patient Testimonials Under New NMC Guidelines

Policy2 sources

Bryan Johnson Says He Would Never Trust His Health to AI Despite Gathering 4.2 Billion Data Points

Tech entrepreneur Bryan Johnson, known for his extreme longevity regimen, warns against trusting AI for health decisions despite its potential. As one in four Americans use AI chatbots for medical advice, experts highlight risks including AI hallucinations, incomplete patient data, and misinformation that could compromise healthcare outcomes.

Health2 sources

Bryan Johnson Says He Would Never Trust His Health to AI Despite Gathering 4.2 Billion Data Points

Health2 sources

Prev12 3 4…20 Next